Skip to main content

MK-677 vs Hexarelin

Both MK-677 and Hexarelin are used for growth-hormone. Here's how their evidence, dosing, and regulatory status actually compare.

MK-677

Evidence B+

Ibutamoren (MK-677)

An orally active ghrelin-receptor agonist that drives 24-hour increases in GH and IGF-1. Technically a non-peptide small molecule but always grouped with GH peptides.

View full MK-677 profile →

Hexarelin

Evidence B

Hexarelin (HEX)

The strongest GH-releasing hexapeptide and one of the few peptides with documented direct cardiac benefits in animal models. Tachyphylaxis (diminished response over time) limits long-term use.

View full Hexarelin profile →

Side-by-Side

AttributeMK-677Hexarelin
Evidence GradeB+B
FDA StatusNot FDA-approved — investigational (orally active GH secretagogue)Not FDA-approved — research compound (cardioprotective signals investigated)
Typical Dose10–25 mg orally, once daily100 mcg, 1–2 times daily (subcutaneous)
Clinics Indexed16541
Categoriesgrowth-hormone, anti-aginggrowth-hormone, recovery

Key reported benefits — MK-677

  • Sustained GH/IGF-1 elevation
  • Sleep depth
  • Lean mass
  • Bone density

Key reported benefits — Hexarelin

  • Strongest GH spike of GHRPs
  • Cardioprotective signals
  • Recovery

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons